New research offers fresh hope to patients with colorectal cancer, as advances in liquid biomarker technologies are ...
Morgan Stanley’s pivot is from “chip winners” to hyperscalers with AI infrastructure optionality. MSFT has the strongest mix ...
July 6 (Reuters) - Morgan Stanley said the recent weakness in U.S. semiconductor stocks is a sign that the market gains are ...
Asianet Newsable on MSN
Morgan Stanley warns chip stocks momentum is fading, favors three hyperscalers — JPMorgan says AI ‘unlikely’ to be only trade in town
According to a Bloomberg report citing a Morgan Stanley note, the firm picked Microsoft, Amazon, and Meta as its favorites ...
Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results